Mode
Text Size
Log in / Sign up

Concurrent training improves exercise capacity and quality of life in older COPD patientsWalking Farther With COPD May Come Down to One Weekly Number

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider concurrent training for improving exercise capacity in COPD, but note limited safety data.

This systematic review and meta-analysis evaluated concurrent training (CT) in 1,037 older adult patients with COPD, focusing on exercise capacity and quality of life. The intervention involved CT, with no specific comparator detailed, and outcomes included 6-min walk distance (6MWD), VO2max, leg press 1RM (LP 1RM), chest press 1RM (CP 1RM), SGRQ score, FVC, FEV1, and FEV1/FVC.

Main results showed significant improvements: 6MWD increased by a mean difference (MD) of 44.08 (95% CrI: 33.35–54.72), VO2max by MD 1.02 (95% CrI: 0.04–2.00), LP 1RM by MD 30.53 (95% CrI: 3.38–57.71), CP 1RM by MD 12.20 (95% CrI: 2.77–21.59), and SGRQ score improved by MD -8.65 (95% CrI: -10.79 to -6.51). However, FVC, FEV1, and FEV1/FVC showed no significant improvement. A nonlinear dose–response relationship identified an optimal CT dose of 1,220 MET-min/week for 6MWD, with MD 24.83 (95% CrI: 14.96–34.70).

Safety and tolerability were not reported, including adverse events, serious adverse events, and discontinuations. Key limitations were not specified in the input, but the absence of safety data and detailed comparator information restricts interpretation. In practice, CT may enhance functional outcomes in COPD, but clinicians should consider the observational nature of this evidence and lack of safety profiles when recommending it.

  • Mixing cardio and strength training boosts walking distance and daily comfort in COPD.
  • Helps older adults whose breathing problems limit walking, stairs, and errands.
  • Lung function itself barely changes — the gain is in stamina, not airways.

The walk to the mailbox

For many people with chronic obstructive pulmonary disease (COPD), the simple act of walking to the mailbox can feel like climbing a hill.

Breath gets short. Legs feel heavy. And the world starts to shrink to whatever is within a few steps of the couch.

A new study published in Frontiers in Medicine offers a hopeful update for that exact problem.

COPD is a long-term lung disease that makes it hard to push air out of your lungs. It affects hundreds of millions of people worldwide and is one of the top causes of death.

The frustrating part is that even the best inhalers do not fully fix the breathlessness. Many patients still feel limited in everyday life.

That is why doctors have been searching for ways to improve daily function, not just lung numbers on a chart.

The shift in how we train the lungs

For years, the standard advice for COPD was simple cardio — walking, cycling, or treadmill work in pulmonary rehab.

Strength training was sometimes added, but often as an afterthought.

But here's the twist: this new review suggests that doing both together — known as "concurrent training" — may give patients a bigger boost than cardio alone.

In other words, lifting weights is not just for athletes. It may be one of the most underused tools for people struggling to breathe.

Think of your body as a team

Imagine your body as a delivery truck.

Your lungs are the engine. Your heart is the fuel pump. Your muscles are the wheels.

If the engine is damaged (as in COPD), you cannot easily fix it. But you can upgrade the wheels and the fuel pump so the whole truck still moves better with the same engine.

That is what concurrent training does. It strengthens leg and chest muscles so they need less oxygen to do the same work, while also training the heart and lungs to deliver oxygen more efficiently.

The team pulled together 20 randomized clinical trials covering 1,037 COPD patients.

They used a careful statistical method (a Bayesian meta-analysis) to combine the results and look not just at whether exercise helps, but how much exercise works best.

The results were encouraging.

People who did concurrent training walked about 44 meters farther in a 6-minute walking test than those who did not. That is roughly the length of an Olympic swimming pool — a real, noticeable difference for someone who used to run out of breath crossing a parking lot.

Strength jumped too. Leg-press strength went up by about 30 pounds on average, and chest-press strength climbed by around 12 pounds.

Quality of life scores also improved meaningfully on a standard COPD survey, suggesting people felt better in their daily lives — not just on a treadmill.

This does not mean exercise can replace COPD medications.

But there's a catch

The training did almost nothing to change actual lung function tests like FEV1 (the amount of air you can blow out in one second).

In other words, the lungs themselves were not "healed." What changed was how well the rest of the body used the air the lungs could deliver.

That is a critical distinction — and a very honest one.

The sweet spot

One of the most interesting findings was about dose.

The researchers found a nonlinear pattern: more exercise helped, but only up to a point. The peak benefit for walking distance came at about 1,220 MET-minutes per week.

In plain terms, that is roughly 200 to 250 minutes per week of moderate-to-vigorous activity that mixes cardio and strength. Pushing harder than that did not add much extra benefit and could risk burnout or injury.

Where this fits in the bigger picture

This research lines up with a growing view in pulmonary medicine: rehab programs should be more than walking laps in a hallway.

Adding resistance training — even with light weights, bands, or bodyweight moves — appears to give patients more functional independence.

For older adults especially, that can mean the difference between climbing stairs on their own and needing help.

If you or a loved one has COPD, this is a good reason to talk to your doctor or pulmonary rehab team about adding strength work to any cardio routine.

You should not start a new exercise program on your own without medical guidance, especially if your COPD is moderate or severe. But the message is clear: movement, done right, is medicine.

Even small, supervised steps could help you walk farther and breathe a little easier through the day.

Honest limits

This was a review of existing studies, not a single large trial. The included studies varied in design, length, and patient severity.

That means the "ideal dose" of 1,220 MET-minutes is a best estimate, not a prescription. Real-world results will vary from person to person.

Future trials will likely test concurrent training in more specific groups — for example, people with severe COPD, those on oxygen, or older adults with multiple conditions.

Researchers also want to fine-tune the mix of cardio and strength, and learn how long the benefits last after a program ends. For now, the takeaway is simple and steady: training both heart and muscles, at the right dose, may help people with COPD reclaim a little more of their day.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
ObjectiveThis systematic review and meta-analysis aimed to assess the effect of concurrent training (CT) on exercise capacity and quality of life in patients with chronic obstructive pulmonary disease (COPD), and to identify the optimal CT dose to enhance 6-min walk distance (6MWD).MethodsRelevant randomized controlled trials (RCTs) examining the effects of CT on exercise capacity and quality of life in patients with COPD were identified through a comprehensive search of PubMed, Embase, Web of Science, Cochrane Library, Scopus, and SPORTDiscus. A multilevel Bayesian random-effects model was used to conduct both pairwise and dose–response meta-analyses.ResultsA total of 1,037 COPD patients were included in the 20 studies. Based on pairwise comparisons, CT was found to significantly improve 6MWD (MD: 44.08; 95% CrI: 33.35–54.72; SD: 20.85; 95% CrI: 13.29–32.26), VO2max (MD: 1.02; 95% CrI: 0.04–2.00; SD: 0.91; 95% CrI: 0.23–2.12), LP 1RM (MD: 30.53; 95% CrI: 3.38–57.71; SD: 2.52; 95% CrI: 0.04–15.19), CP 1RM (MD: 12.20; 95% CrI: 2.77–21.59; SD: 2.44; 95% CrI: 0.05–10.71), and SGRQ score (MD: −8.65; 95% CrI: −10.79 to −6.51; SD: 5.04; 95% CrI: 2.52–8.99). However, no significant improvement was observed in FVC, FEV1, and FEV1/FVC. Additionally, a nonlinear dose–response relationship was observed between CT and 6MWD, with the optimal dose identified as 1,220 MET-min/week (MD = 24.83; 95% CrI: 14.96–34.70).ConclusionsCT was found to significantly improve exercise capacity and quality of life in COPD patients, while showing limited effects on pulmonary function indicators. Moreover, a nonlinear dose–response relationship was identified between CT and 6MWD, with the most pronounced effects observed at a weekly dose of 1,220 MET-min.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, CRD42025630487.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.